Albemarle Corporation

ALB Basic Materials Specialty Chemicals

Albemarle Corporation’s revenue for fiscal 2025 (year ended December 2025) was $5.1 billion, down 4.37% from fiscal 2024. In the quarter to June 2026, revenue grew 31.1%, EPS grew 2,425.0%, free cash flow grew 708.4% and total debt fell 48.2%, each against the same quarter a year earlier. Member of the S&P 500; dividend growth for ten consecutive years.

95.48 2.70 −2.75%
Market cap
$11.6B
P/E
199×
Fwd P/E
14.9×
Dividend yield
1.70%
F-score
6/9
Altman Z
2.31
Beneish M
−3.71
Dividend safety
47/100
Jun '26 Mar '26 Dec '25 Sep '25 Older periods
ROE
0.69% (5.02%) (8.73%) (2.31%)

+8 more TTM periods

Piotroski F-Score
7 6 6 5
ROA
0.35% (2.49%) (4.11%) (1.09%)
ROIC
1.46% (0.88%) (2.02%) (0.76%)
Return on Tangible Assets
0.55% (3.91%) (6.26%) (1.60%)
Average Days of Receivables
44.96 43.81 49.58 62.07
Free Cash Flow per Share
11.46 5.16 6.16 1.42
Free Cash Flow
1,351.43 608.26 725.28 166.93
Capital Expenditures
(448.89) (473.04) (556.99) (722.47)
Other line items
Cash ROIC
9.62% 4.65% 4.97% 1.05%
Accounts Receivable Turnover
7.35 7.49 6.13 5.32
Accounts Payable Turnover
4.56 4.84 4.82 3.30
Inventory Turnover
2.98 2.98 3.34 2.72
Average Days of Payables
90.47 76.06 74.53 118.16
Days of Inventory on Hand
112.28 109.71 96.21 128.97
Tax Rate
(1.41) 0.65 0.28 0.05
Research and Development Expense of Revenue
0.64% 0.85% 1.00% 1.20%
Selling, General and Administrative Expense of Revenue
9.44% 10.26% 10.70% 10.73%
Share Based Compensation of Revenue
0.64% 0.75% 0.78% 0.72%
Interest Coverage
1.46 (0.80) (1.77) (0.75)
Operating CF/Net income
31.35 (2.71) (1.89) (4.73)
Depreciation/Fixed assets
0.10 0.10 0.10 0.09
Capex/Depreciation
(0.55) (0.57) (0.66) (0.86)
Revenue per Share
50.08 46.62 43.71 42.03
Operating CF per Share
15.26 9.17 10.90 7.56
Capex per Share
(3.81) (4.01) (4.73) (6.14)
Capex to Sales
0.08 0.09 0.11 0.15

Fold the line items

Columns are period end dates